DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+28.73%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.68B
AUM Growth
+$2.68B
(+8.7%)
Cap. Flow
-$199M
Cap. Flow
% of AUM
-7.42%
Top 10 Holdings %
Top 10 Hldgs %
42.9%
Holding
149
New
19
Increased
23
Reduced
32
Closed
38
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$79.6M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
$40.5M |
| 3 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$35.8M |
| 4 |
Vanda Pharmaceuticals
VNDA
|
$28.2M |
| 5 |
AGN
ALLERGAN INC
AGN
|
$24.5M |
Top Sells
| 1 |
KITE
Kite Pharma, Inc.
KITE
|
$49.4M |
| 2 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$46M |
| 3 |
AbbVie
ABBV
|
$44.3M |
| 4 |
BLUE
bluebird bio
BLUE
|
$37.4M |
| 5 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$30.9M |
Sector Composition
| 1 | Healthcare | 54.5% |
| 2 | Financials | 2.8% |
| 3 | Technology | 0.75% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUXL
1
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $216M | 7.74% | 6,267,382 | – | – |
|
|
ASPX
2
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
| $155M | 5.56% | 2,949,103 +436,943 | +17% | +$22.9M |
|
|
HZNP
3
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $151M | 5.42% | 11,699,047 +6,178,481 | +112% | +$79.6M |
|
|
AGN
4
DELISTED
ALLERGAN INC
AGN
| $129M | 4.63% | 606,601 +115,202 | +23% | +$24.5M |
|
|
AVDL
5
Avadel Pharmaceuticals
AVDL
$1.43B
| $90.1M | 3.24% | 5,258,475 | – | – |
|
6
Adverum Biotechnologies
ADVM
$64.6M
| $87.2M | 3.13% | 1,614,669 -433,010 | -21% | -$23.4M |
|
|
NXTM
7
DELISTED
NxStage Medical Inc.
NXTM
| $86.3M | 3.1% | 4,811,494 -1,329,600 | -22% | -$23.8M |
|
|
BLUE
8
DELISTED
bluebird bio
BLUE
| $78M | 2.8% | 850,932 -407,755 | -32% | -$37.4M |
|
|
INFI
9
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $65.2M | 2.34% | 3,857,805 -25,000 | -0.6% | -$422K |
|
|
RNA
10
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
| $62.2M | 2.23% | 3,316,434 +717,975 | +28% | +$13.5M |
|
|
11
Vanda Pharmaceuticals
VNDA
$279M
| $59.3M | 2.13% | 4,139,787 +1,971,112 | +91% | +$28.2M |
|
12
eHealth
EHTH
$118M
| $56.4M | 2.03% | 2,264,588 | – | – |
|
|
ARRY
13
DELISTED
Array Biopharma Inc
ARRY
| $56M | 2.01% | 11,834,595 -371,078 | -3% | -$1.76M |
|
|
AERI
14
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $54.3M | 1.95% | 1,858,917 -466,000 | -20% | -$13.6M |
|
|
UAM
15
DELISTED
Universal American Corp
UAM
| $52.1M | 1.87% | 5,614,798 -379,720 | -6% | -$3.52M |
|
|
ELGX
16
DELISTED
Endologix Inc
ELGX
| $51.7M | 1.86% | 3,378,787 +877,261 | +35% | +$13.4M |
|
|
NVRO
17
DELISTED
NEVRO CORP.
NVRO
| $40.5M | 1.45% | +1,047,093 | New | +$40.5M |
|
18
Pacific Biosciences
PACB
$393M
| $40.1M | 1.44% | 5,120,771 +721,439 | +16% | +$5.66M |
|
|
ACHN
19
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $35.8M | 1.29% | +2,920,300 | New | +$35.8M |
|
20
Insmed
INSM
$28.8B
| $34.7M | 1.25% | 2,241,631 +161,471 | +8% | +$2.5M |
|
21
DaVita
DVA
$9.85B
| $32.9M | 1.18% | 435,000 -207,425 | -32% | -$15.7M |
|
22
Tempest Therapeutics
TPST
$44M
| $27.7M | 1% | 627,050 -508,123 | -45% | -$22.5M |
|
|
ARNA
23
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $24.1M | 0.87% | 6,953,737 +1,105,738 | +19% | +$3.84M |
|
24
GSK
GSK
$79.9B
| $24.1M | 0.86% | 563,300 +163,300 | +41% | +$6.98M |
|
|
ALIM
25
DELISTED
Alimera Sciences, Inc.
ALIM
| $22.4M | 0.81% | 4,045,826 +2,193,936 | +118% | +$12.2M |
|